About Nilsan Pharmaceuticals
Nilsan Pharmaceuticals is a Healthcare company based in Delhi (India) founded in 1997. It manufactures and markets a wide range of prescription, over-the-counter medications, nutraceuticals, and cosmeceuticals. It operates on a B2B model. Its Indian entity Nilsan Pharmaceuticals Private Limited reported revenue of ₹17.12 Cr. Its focus areas include Pharmaceuticals, Drug Manufacturing and Prescription and OTC Products. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.
Company details
Nilsan Pharmaceuticals, established in 1997, excels in providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and prescription and otc products. Manufactures and markets a wide range of prescription, over-the-counter medications, nutraceuticals, and cosmeceuticals. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters Delhi, India
- SectorsHealthcare
- Website ww12.nilsanpharmaceuticals.com/?usid=26&utid=11205629314
- Legal Name Nilsan Pharmaceuticals Private Limited
- Date of Incorporation 18 Jul, 1996
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹17.12 Cr
FY 2025 · -9% YoY
- Net Profit₹35.2 Lakh
FY 2025 · 2% margin
- EBITDA₹1.34 Cr
FY 2025 · 8% margin
Associated legal entities of Nilsan Pharmaceuticals
Nilsan Pharmaceuticals operates through Nilsan Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nilsan Pharmaceuticals Private Limited CIN U74210DL1996PTC080481 | Active | 18 Jul 1996 | New Delhi, Delhi | ₹17.1 Cr | 2 | View details |
Board of directors of Nilsan Pharmaceuticals Private Limited (Nilsan Pharmaceuticals)
Nilsan Pharmaceuticals Private Limited is the primary company behind Nilsan Pharmaceuticals. The board of Nilsan Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Sandeep Kumar Garg, appointed in 1996. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sandeep Kumar Garg DIN 00407215 | Director | 18 Jul 1996 | 30 yrs 3 mo | Nilsan Pharmaceuticals Private Limited |
| Kavita Garg DIN 07008997 | Director | 01 Oct 2013 | 13 yrs | Nilsan Pharmaceuticals Private Limited |
Financials of Nilsan Pharmaceuticals
Figures of Nilsan Pharmaceuticals Private Limited, the primary company behind Nilsan Pharmaceuticals, for FY 2025. Revenue was ₹17.12 Cr (-9% year on year). Net profit was ₹35.2 Lakh (2% margin). EBITDA was ₹1.34 Cr (8% margin). Revenue has grown at a compounded annual rate of -8% over three years and -3% over five years.
- ₹17.12 CrRevenue · FY 2025 · -9% YoY
- ₹35.2 LakhNet profit · 2% margin
- ₹1.34 CrEBITDA · 8% margin
- ₹20 LakhPaid-up capital
- -8%Revenue CAGR, 3 years
- -3%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Nilsan Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Nilsan Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Nilsan Pharmaceuticals
Nilsan Pharmaceuticals has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| sandor.co.in | 1995 | Hyderabad, India | $8.98M | 161 | Provider of medical equipment, devices, and drugs distribution services |
Detailed similar companies of Nilsan Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nilsan Pharmaceuticals
Nilsan Pharmaceuticals was founded in 1997.
Nilsan Pharmaceuticals is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
The primary company behind Nilsan Pharmaceuticals, Nilsan Pharmaceuticals Private Limited, reported revenue of ₹17.12 Cr for FY 2025, down 9% year on year.
Nilsan Pharmaceuticals, established in 1997, excels in providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and prescription and otc products. Manufactures and markets a wide range of prescription, over-the-counter medications, nutraceuticals, and cosmeceuticals. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Nilsan Pharmaceuticals's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.
Nilsan Pharmaceuticals operates through Nilsan Pharmaceuticals Private Limited.
The legal entities of Nilsan Pharmaceuticals currently have 2 directors, including Kavita Garg, Sandeep Kumar Garg.